Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Kucheman William
 2. Date of Event Requiring Statement (Month/Day/Year)
10/31/2006		 3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [(BSX)]
(Last)
(First)
(Middle)
C/O BOSTON SCIENTIFIC CORPORATION, ONE BOSTON SCIENTIFIC PLACE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP & Group President
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NATICK, MA 01760		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 2,844
D
 
Common Stock 23,471
I
By 401(k)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units   (1)   (1) Common Stock 21,500 $ (2) D  
Stock Option (Right to Buy)   (3) 05/09/2010 Common Stock 6,000 $ 14.16 D  
Stock Option (Right to Buy)   (4) 07/25/2010 Common Stock 6,000 $ 8.5 D  
Stock Option (Right to Buy)   (5) 12/06/2010 Common Stock 11,668 $ 6.13 D  
Stock Option (Right to Buy)   (6) 07/17/2011 Common Stock 25,000 $ 8.99 D  
Stock Option (Right to Buy)   (7) 12/17/2011 Common Stock 11,000 $ 12.5 D  
Stock Option (Right to Buy)   (8) 12/09/2012 Common Stock 32,000 $ 21.26 D  
Stock Option (Right to Buy)   (9) 12/11/2013 Common Stock 13,000 $ 34.79 D  
Stock Option (Right to Buy)   (10) 06/15/2014 Common Stock 100,000 $ 41.98 D  
Stock Option (Right to Buy)   (11) 01/03/2015 Common Stock 29,233 $ 34.29 D  
Stock Option (right to buy)   (12) 07/01/2015 Common Stock 49,700 $ 26.89 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Kucheman William
C/O BOSTON SCIENTIFIC CORPORATION
ONE BOSTON SCIENTIFIC PLACE
NATICK, MA 01760		       SVP & Group President  

Signatures

By: /s/ Lawrence J. Knopf, Attorney-in-fact 11/02/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on July 1, 2007, the second anniversary of the award, provided the reporting person continues to be an employee of Boston Scientific or in certain circumstances upon the reporting person's retirement from the Company.
(2) Each deferred stock unit represents the Company's promise to issue one share of Boston Scientific common stock.
(3) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on May 9, 2001, 50% on May 9, 2002, 75% on May 9, 2003 and 100% on May 9, 2004, the anniversary date of the grant.
(4) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on July 25, 2001, 50% on July 25, 2002, 75% on July 25, 2003 and 100% on July 25, 2004, the anniversary date of the grant.
(5) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable in approximately equal annual increments on December 6, 2001, 2002 and 2003, the anniversary date of this grant.
(6) Grant to the reporting person of an option to purchase a specified number of shares of common stock of the Company exercisable in equal annual increments on July 17, 2002, 2003, 2004 and 2005, the anniversary date of the grant.
(7) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 17, 2002, 50% on December 17, 2003, 75% on December 17, 2004 and 100% on December 17, 2005, the anniversary date of the grant.
(8) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 9, 2003, 50% on December 9, 2004, 75% on December 9, 2005 and 100% on December 9, 2006, the anniversary date of the grant.
(9) Grant to the reporting person of an option to purchase a specified number of shares exercisable in equal annual installments beginning on December 11, 2004, 2005, 2006 and 2007, the anniversary date of the grant.
(10) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable in equal annual increments on June 15, 2008, 2009 and 2010, the anniversary date of this grant.
(11) Grant to the reporting person of an option to buy a specified number of shares of common stock of the Company exercisable in equal annual installments on January 3, 2006, 2007, 2008 and 2009, the anniversary date of the grant.
(12) Grant to the reporting person of an option to buy a specified number of shares of common stock of the Company exercisable in equal annual installments on July 1, 2007, 2008, 2009, 2010 and 2011, the anniversary date of the grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.